GeneGo, Inc., a leading provider of software and databases for systems biology, has announced that the Translational Genomics Research Institute (TGen) had licensed MetaCore, GeneGo's platform for mining of high-throughput experimental data in the context of human and mammalian "interactome" and common diseases.

MetaCore is designed to process "genome scale" data files including microarrays and SAGE gene expression, proteomics and metabolomics. MetaCore applies multiple algorithms for generation, comparison and functional interpretation of biological networks and pathways.

"We evaluated MetaCore and decided that it was a good fit for TGen," said Dr. Edward Suh, TGen's Chief Information Officer. "GeneGo enables our scientists to generate global pathways and smaller targeted networks, and in addition, extending pathways and networks with GeneGo was a very attractive feature for gaining information," he added.

"We are very pleased to be working with TGen in aiding their mission to make and translate genomic discoveries into advances in human health that will that have a direct impact on patients", said Julie Bryant, VP of business development at GeneGo.

The Translational Genomics Research Institute (TGen) is a not-for-profit organization is involved in translate genomic discoveries into advances in human health.